This month, Democracy Now! marks 29 years of fearless independent journalism. Presidents have come, gone and come back again, but Democracy Now! remains, playing the same critical role in our democracy: shining a spotlight on corporate and government abuses of power and raising up the voices of scholars, advocates, scientists, activists, artists and ordinary people working for a more peaceful and just world. If our journalism is important to you, please donate today in honor of our 29th anniversary. Every dollar makes a difference. Thank you so much.
Democracy Now!
Amy Goodman
This month, Democracy Now! marks 29 years of fearless independent journalism. Presidents have come, gone and come back again, but Democracy Now! remains, playing the same critical role in our democracy: shining a spotlight on corporate and government abuses of power and raising up the voices of scholars, advocates, scientists, activists, artists and ordinary people working for a more peaceful and just world. If our journalism is important to you, please donate today in honor of our 29th anniversary. Every dollar makes a difference. Thank you so much.
Democracy Now!
Amy Goodman
We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.
Please do your part today.
StoryFeb 21, 2025
StoryFeb 21, 2025
StoryFeb 21, 2025
StoryFeb 20, 2025
Web ExclusiveFeb 17, 2025
Web ExclusiveFeb 13, 2025
Web ExclusiveFeb 11, 2025
Web ExclusiveFeb 11, 2025
And the U.S. Food and Drug Administration has approved a cannabis-based drug for the first time. The drug, Epidiolex, has been approved to treat two types of epileptic syndromes. The drug’s approval comes as an increasing number of states have approved medicinal and recreational marijuana use.
Top